Paper8306044
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz DA and 7 others. Am J Respir Crit Care Med, 1994. Cited by 281 papers, by iCite.
Cite this record
ConductScience Library. Determinants of survival in idiopathic pulmonary fibrosis. Papers, record 8306044. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8306044
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchoalveolar Lavage Fluid | Major topic |
| Pulmonary Fibrosis | Major topic |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Predictive Value of Tests | |
| Prospective Studies | |
| Regression Analysis | |
| Sex Factors | |
| Smoking | |
| Spirometry | |
| Survival Analysis | |
| Time Factors |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-37121 | NHLBI NIH HHS | United States | P50HL037121 | PubMed and NIH | NIH RePORTER |
| OH00093-01 | NIOSH CDC HHS | United States | PubMed | PubMed | |
| RR-00059 | NCRR NIH HHS | United States | M01RR000059 | PubMed and NIH | NIH RePORTER |
| K01OH000093 | NIH | NIH RePORTER |
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 281 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42706338 | Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42706338 | PubMed |
| 41132946 | Exploring the Impact of Telerehabilitation on Physical Performance in Patients with Pulmonary Fibrosis. | Telemed Rep | 2025 | https://conductscience.org/library/papers/41132946 | PubMed |
| 40820275 | Age-related diseases as a testbed for anti-aging therapeutics: the case of idiopathic pulmonary fibrosis. | Aging (Albany NY) | 2025 | https://conductscience.org/library/papers/40820275 | PubMed |
| 40785882 | What role does artificial intelligence-driven quantitative analysis of chest computed tomography play in providing pulmonary function for idiopathic pulmonary fibrosis patients undergoing pirfenidone treatment? | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40785882 | PubMed |
| 39855300 | Piezo2 Is a Key Mechanoreceptor in Lung Fibrosis that Drives Myofibroblast Differentiation. | Am J Pathol | 2025 | https://conductscience.org/library/papers/39855300 | PubMed |
| 39479511 | Revisiting the role of MicroRNAs in the pathogenesis of idiopathic pulmonary fibrosis. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39479511 | PubMed |
| 38774483 | Effects of Natural Products through Inhibiting Endoplasmic Reticulum Stress on Attenuation of Idiopathic Pulmonary Fibrosis. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/38774483 | PubMed |
| 38384288 | Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: results of a retrospective analysis of a large insurance database in Taiwan. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38384288 | PubMed |
| 38112764 | Deep learning-based prognostication in idiopathic pulmonary fibrosis using chest radiographs. | Eur Radiol | 2024 | https://conductscience.org/library/papers/38112764 | PubMed |
| 37883007 | Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan. | Drugs Real World Outcomes | 2024 | https://conductscience.org/library/papers/37883007 | PubMed |
| 37605652 | Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies. | EPMA J | 2023 | https://conductscience.org/library/papers/37605652 | PubMed |
| 36550474 | Medium-long term prognosis prediction for idiopathic pulmonary fibrosis patients based on quantitative analysis of fibrotic lung volume. | Respir Res | 2022 | https://conductscience.org/library/papers/36550474 | PubMed |
| 35782232 | Quantitative analysis of high-resolution computed tomography features of idiopathic pulmonary fibrosis: a structure-function correlation study. | Quant Imaging Med Surg | 2022 | https://conductscience.org/library/papers/35782232 | PubMed |
| 35548360 | Engineering of Stimulus-Responsive Pirfenidone Liposomes for Pulmonary Delivery During Treatment of Idiopathic Pulmonary Fibrosis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35548360 | PubMed |
| 35418487 | Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives. | Eur Respir Rev | 2022 | https://conductscience.org/library/papers/35418487 | PubMed |
| 34865413 | Prevalence and impact of airway diseases on clinical outcomes in idiopathic pulmonary fibrosis. | Korean J Intern Med | 2022 | https://conductscience.org/library/papers/34865413 | PubMed |
| 34685461 | A Soft Voting Ensemble-Based Model for the Early Prediction of Idiopathic Pulmonary Fibrosis (IPF) Disease Severity in Lungs Disease Patients. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34685461 | PubMed |
| 34575245 | The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis. | J Clin Med | 2021 | https://conductscience.org/library/papers/34575245 | PubMed |
| 32853277 | Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis. | PLoS One | 2020 | https://conductscience.org/library/papers/32853277 | PubMed |
| 32569216 | A score without diffusion capacity of the lung for carbon monoxide for estimating survival in idiopathic pulmonary fibrosis. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32569216 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8306044
GET https://conductscience.org/api/papers/v1/8306044/cited_by?page=2